'In alignment with Astellas' patient-centric approach focused on supporting innovative health solutions beyond medicine through a deep understanding of the patient experience, REPROSENT honors the perspective and needs of patients with an outcomes-based digital app that complements in-person touchpoints,' said
After losing her father in 2020 to a cancer immunotherapy adverse reaction, DeGolyer founded REPROSENT and developed a mobile app to help cancer patients track their own symptom data, enabling them to have greater control in their treatment. The app aims to reduce clinical team burden, drive deeper understanding of the patient's daily data and improve outcomes.
'Cancer patients need better inclusion in their care, and our app and reports inform clinical conversations to manage what is most important - the patient's lived experience,' said DeGolyer. 'Patients or their caregivers can log symptoms in the app daily and provide the data to their healthcare providers to help them make more informed decisions tailored to the patient.'
With the funds from the C3 Prize, REPROSENT will be able to gather more data, faster, and scale access to more patients in the cancer community.
'The Astellas Oncology C3 Prize gives people with a passion for healthcare innovation an opportunity to pursue ideas and solutions that may make a difference in the lives of people living with cancer, their loved ones and those who care for them,' said
A panel of volunteer judges who are leaders in innovation, healthcare and business selected the Grand Prize winner. Judges included:
This year's challenge awarded a Grand Prize of
About Astellas
About the Astellas Oncology C3 Prize
The Astellas Oncology C3 Prize, launched in 2016, is a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine. The C3 Prize sparks innovative developments in cancer care, tackling cancer challenges by awarding the winners with prize money and connecting them with resources and support. The C3 Prize directly reflects the mission of Astellas Oncology: striving to make every day better for those impacted by cancer. Astellas maintains no ownership in the ventures funded by the C3 Prize.
About MATTER
At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 700 current and alumni startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.
About Slalom
Slalom is a global consulting firm focused on strategy, technology, and business transformation. In 43 markets around the world, Slalom's teams have autonomy to move fast and do what's right. They are backed by regional innovation hubs, a global culture of collaboration, and partnerships with the world's top technology providers. Founded in 2001 and headquartered in
Contact:
Astellas
T: (847) 686-1813
E: tara.grayczyk@astellas.com
(C) 2022 Electronic News Publishing, source